- NYU Brooklyn: What is the preferred treatment for management of C. Diff?
- Bellevue Inpatient: Can patients with statin-associated immune-mediated necrotizing myopathy (IMNM) with confirmed positive anti-HMG-CoA-reductase antibodies be re-challenged with statins or treated with PCSK9 inhibitors?
- Bellevue Outpatient: What is the role of GLP1-agonists when used for weight loss in patients without diabetes?
Author: Christian Torres
Clinical Correlations
Primecuts – This Week in the Journals
May 14, 2021
By Kyra Hansson Floyd, MD
Peer Reviewed
With medicine advancing at such a rapid pace, it is crucial for physicians to keep up with the medical literature. This can quickly become an overwhelming endeavor given the sheer …
The New Kid on the Block: Heart Failure with Mid-Range Ejection Fraction (HFmrEF)
May 12, 2021
By Pamela Boodram, MD
Peer Reviewed
A 68-year-old woman with a history of hypertension and well controlled type 2 diabetes presents to the ED with five days of progressively worsening dyspnea on exertion, orthopnea, and …
The History and Clinical Utility of Eponymous Triads
May 10, 2021
By Joshua Novack
Peer Reviewed
Beginning in medical school, in between lectures on biochemistry, anatomy, and physiology, students begin to learn the physical exam and its role in the diagnosis of medical conditions. Some of …
Primecuts – This Week in the Journals
April 30, 2021
By Tyler B. Fugere, MD
Peer Reviewed
With medicine advancing at such a rapid pace, it is crucial for physicians to keep up with the medical literature. This can quickly become an overwhelming endeavor given …
Should patients on DAPT after ACS receive prophylactic PPIs?
April 19, 2021
By Peter Sheng, MD, MPH
Peer Reviewed
Dual antiplatelet therapy (DAPT) has become the standard of care for patients after acute coronary syndrome (ACS) [1]. It is important, however, to consider the risk of gastrointestinal …
Primecuts – This Week in the Journals
April 16, 2021
By Lily Cao, MD
Peer Reviewed
A Placebo-Controlled Trial of Subcutaneous Semaglutide in Nonalcoholic Steatohepatitis [1]
Nonalcoholic steatohepatitis (NASH) is commonly diagnosed in primary care. We often counsel patients on diet and exercise, recommend vaccinations, and …
The Shifting Paradigm of Antimicrobial Research
April 14, 2021
By Avani Kolla
Peer Reviewed
During my trip to India, the “family bonding” reached a new level when I shared my upper respiratory infection with my parents and sister. On day two of my father’s …